company background image
1066 logo

Shandong Weigao Group Medical Polymer SEHK:1066 株式レポート

最終価格

HK$4.33

時価総額

HK$19.8b

7D

0%

1Y

-58.0%

更新

19 Jun, 2024

データ

会社財務 +

Shandong Weigao Group Medical Polymer Company Limited

SEHK:1066 株式レポート

時価総額:HK$19.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

1066 株式概要

山東維高集団医療高分子有限公司は、中華人民共和国において医療機器の研究開発、製造、卸売、販売を行っている。

1066 ファンダメンタル分析
スノーフレーク・スコア
評価6/6
将来の成長1/6
過去の実績2/6
財務の健全性6/6
配当金4/6

Shandong Weigao Group Medical Polymer Company Limited 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめShandong Weigao Group Medical Polymer
過去の株価
現在の株価HK$4.33
52週高値HK$10.74
52週安値HK$4.30
ベータ0.35
11ヶ月の変化-18.46%
3ヶ月変化-17.99%
1年変化-57.96%
33年間の変化-77.23%
5年間の変化-38.23%
IPOからの変化2,410.14%

最新ニュース

Recent updates

Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

May 22
We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Apr 23
Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Mar 17
Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital Are Heading Higher

Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Jan 28
Is There An Opportunity With Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 42% Undervaluation?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Jan 13
Does Shandong Weigao Group Medical Polymer (HKG:1066) Deserve A Spot On Your Watchlist?

Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 17
Returns Are Gaining Momentum At Shandong Weigao Group Medical Polymer (HKG:1066)

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Dec 05
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Oct 18
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 32% Undervalued

Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Oct 06
Do Shandong Weigao Group Medical Polymer's (HKG:1066) Earnings Warrant Your Attention?

Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Sep 10
Shandong Weigao Group Medical Polymer (HKG:1066) Shareholders Will Want The ROCE Trajectory To Continue

Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Aug 29
Shandong Weigao Group Medical Polymer (HKG:1066) Has A Rock Solid Balance Sheet

Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Jul 09
Calculating The Fair Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Jun 26
Here's Why I Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)

Jun 02
Investors Met With Slowing Returns on Capital At Shandong Weigao Group Medical Polymer (HKG:1066)

These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well

Apr 24
These 4 Measures Indicate That Shandong Weigao Group Medical Polymer (HKG:1066) Is Using Debt Reasonably Well

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 49% Below Their Intrinsic Value Estimate

Mar 31
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 49% Below Their Intrinsic Value Estimate

株主還元

1066HK Medical EquipmentHK 市場
7D0%0.5%-0.4%
1Y-58.0%-43.4%-1.8%

業界別リターン: 1066過去 1 年間で-43.4 % の収益を上げたHong Kong Medical Equipment業界を下回りました。

リターン対市場: 1066は、過去 1 年間で-1.8 % のリターンを上げたHong Kong市場を下回りました。

価格変動

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement5.4%
Medical Equipment Industry Average Movement7.3%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.3%
10% least volatile stocks in HK Market3.7%

安定した株価: 1066の株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: 1066の 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
200012,519Rinan Congwww.weigaogroup.com

山東維高集団医療高分子有限公司は中華人民共和国において医療機器の研究開発、製造、卸売、販売を行っている。医療機器製品、整形外科製品、インターベンショナル製品、医薬品包装製品、血液管理製品、その他分野で事業を展開。同社は、輸液セット、シリンジ、血液バッグ、血液成分分離器などの消耗品、採血製品、プレパック薬用プレフィルドシリンジ、主に静脈注射針、シリンジ針、静脈カテーテル針、採血針、不規則針などの医療用針を含む単回使用医療消耗品および材料を提供している;鋼板やネジの外傷製品、脊椎インプラント、人工関節を含む整形外科材料および器具、穿刺針、血液浄化セット用体外血液回路、ダイアライザーおよび関連消耗品を含む血液浄化消耗品および機器。また、腫瘍・血管インターベンション器具、洗浄用注射器、採血・照射・保存・分離・滅菌製品、移植材料・人工臓器、医療用PVC顆粒、プラスチック包装袋、カートンボックス、医療用ポリマー材料・製品、注射用穿刺器具、医薬品、X線照射装置なども提供している。また、ファイナンス・リースおよびファクタリング事業、企業管理アドバイザリー・サービス、物流・保管サービス、コンピューター技術サービスの提供、電子製品の販売にも携わっている。同社は2000年に法人化され、中華人民共和国威海市に本社を置く。

Shandong Weigao Group Medical Polymer Company Limited 基礎のまとめ

Shandong Weigao Group Medical Polymer の収益と売上を時価総額と比較するとどうか。
1066 基礎統計学
時価総額HK$19.79b
収益(TTM)HK$2.15b
売上高(TTM)HK$14.23b

9.2x

PER(株価収益率

1.4x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
1066 損益計算書(TTM)
収益CN¥13.23b
売上原価CN¥6.62b
売上総利益CN¥6.61b
その他の費用CN¥4.61b
収益CN¥2.00b

直近の収益報告

Dec 31, 2023

次回決算日

該当なし

一株当たり利益(EPS)0.44
グロス・マージン49.97%
純利益率15.13%
有利子負債/自己資本比率16.8%

1066 の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

4.2%

現在の配当利回り

38%

配当性向